A Phase III, Randomized, Single-Blind, Superiority Study Comparing The Efficacy And Tolerability Of A New Drug Containing The Combination Meloxicam And Cyclobenzaprine And The Same Components Alone In The Treatment Of Acute Lumbago
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 04 May 2016
At a glance
- Drugs Cyclobenzaprine/meloxicam (Primary) ; Cyclobenzaprine; Meloxicam
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Eurofarma
- 29 Apr 2016 Status changed from not yet recruiting to withdrawn prior to enrolment because the comparator product was withdrawn from the brazilian market not being possible to conduct the design regarding initially planned
- 24 Jul 2015 Planned primary completion date changed from 1 Jun 2013 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
- 24 Jul 2015 Planned End Date changed from 1 Sep 2013 to 1 Jun 2017 as reported by ClinicalTrials.gov record.